IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

High Risk Pregnancy · Pregnancy Complications · Antiphospholipid Syndrome in Pregnancy · Lupus Anticoagulant Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital for Special Surgery, New York, New York, United States
Contact: Study coordinator (Marta Guerra, MS) · guerram@hss.edu · 212-774-7361
Contact: Principal Investigator (Jane Salmon, MD)
University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Elizabeth Turner) · elizabeth.e.turner@hsc.utah.edu · 801-585-0591
Contact: Study coordinator (Rose Peckham) · Rose.Peckham@hsc.utah.edu · 801-585-7617
Contact: Principal Investigator (D. Ware Branch, MD)
TRIO Advancing Reproductive Care, Toronto, Ontario, Canada
Contact: Study coordinator (Karen Spitzer, MSc) · kspitzer@triofertility.com · 416-506-9203
Contact: Principal Investigator (Carl Laskin, MD)

Study leads

D. Ware Branch, MD
Principal Investigator
University of Utah

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Preeclampsia Severe · Toxemia Of Pregnancy · Preeclampsia

Abroad (travel likely)RecruitingPHASE4

Athens, Greece